1 |
Ariazi, E.A., Ariazi, J.L., Cordera, F., and Jordan, V.C. (2006). Estrogen receptors as therapeutic targets in breast cancer. Curr. Top. Med. Chem. 6, 195-216
DOI
|
2 |
Kawagoe, J., Ohmichi, M., Takahashi, T., Ohshima, C., Mabuchi, S., Takahashi, K., Igarashi, H., Mori-Abe, A., Saitoh, M., Du, B., et al. (2003). Raloxifene inhibits estrogen-induced up-regulation of telomerase activity in a human breast cancer cell line. J. Biol. Chem. 278, 43363-43372
DOI
ScienceOn
|
3 |
Suuronen, T., Nuutinen, T., Huuskonen, J., Ojala, J., Thornell, A., and Salminen, A. (2005). Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells. Inflamm. Res. 54, 194-203
DOI
|
4 |
Grandage, V.L., Gale, R.E., Linch, D.C., and Khwaja, A. (2005). PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinases and p53 pathways. Leukemia 19, 586- 594
DOI
|
5 |
Cirino, G. (1998). Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase. Biochem. Pharmacol. 55, 105-111
DOI
ScienceOn
|
6 |
Eming, S.A., Krieg, T., and Davidson, J.M. (2007). Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514-525
DOI
ScienceOn
|
7 |
Romashkova, J.A., and Makarov, S.S. (1999). NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401, 86- 90
DOI
ScienceOn
|
8 |
Lee, S.J., Bai, S.K., Lee, K.S., Namkoong, S., Na, H.J., Ha, K.S., Han, J.A., Yim, S.Y., Chang, K., Kwon, Y.G., et al. (2003). Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation. Mol. Cells 16, 97-105
|
9 |
Verhaeghe, C., Remouchamps, C., Hennuy, B., Vanderplasschen, A., Chariot, A., Tabruyn, S.P., Oury, C., and Bours, V. (2007). Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem. Pharmacol. 73, 1982-1994
DOI
ScienceOn
|
10 |
Delmas, P.D., Bjarnason, N.H., Mitlak, B.H., Ravoux, A.C., Shah, A.S., Huster, W.J., Draper, M., and Christiansen, C. (1997). Effects od raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337, 1641-1647
DOI
ScienceOn
|
11 |
Shoji, T., Yoshida, S., Mitsunari, M., Miyake, N., Tsukihara, S., Iwabe, T., Harada, T., and Terakawa, N. (2007). Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua. J. Reprod. Immunol. 75, 82-90
DOI
ScienceOn
|
12 |
Lonard, D.M., and Smith, C.L. (2002). Molecular perspectives on selective estrogen receptor modulators (SERM): progress in understanding their tissue-specific agonist antagonist actions. Steroid 67, 15-24
DOI
ScienceOn
|
13 |
Katznellenbogen, B.S., and Katznellenbogen, J.A. (2002). Defining the "S" in SERMS. Science 295, 2380-2381
DOI
ScienceOn
|
14 |
Lufkin, E.G., Whitaker, M.D., Nickelsen, T., Argueta, R., Caplan, R.H., Knickerbocker, R.K., and Riggs, B.L. (1998). Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial. J. Bone Miner. Res. 13, 1747-1754
DOI
ScienceOn
|
15 |
Esposito, E., Iacono, A., Raso, G..M., Pacilio, M., Coppola, A., Di Cario, R., and Meli, R. (2005). Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats. Endocrinology 146, 3301-3308
DOI
ScienceOn
|
16 |
Grese, T.A., Sluka, J.P., Bryant, H.U., Cullinan, G.J., Glasebrook, A.L., Jones, C.D., Matsumoto, K., Palkowitz, A.D., Sato, M., Termine, J.D., et al. (1997). Molecular determinants of tissue selectivity in estrogen receptor modulator. Proc. Natl. Acad. Sci. USA 94, 14105-141107-672
|
17 |
Hanada, T., and Yoshimura, A. (2002). Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13, 413- 421
DOI
ScienceOn
|
18 |
Kuiper, G.G.J.M., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., vad der Burg, B., and Gustafsson, J.-A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor- . Endocrinology 13, 4252-4263
|
19 |
Laskin, D.L., and Pendino, J. (1995). Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35, 655-677
DOI
ScienceOn
|
20 |
Sherman, M.P., Aeberhard, E.E., Wong, V.Z., Griscavage, J.M., and Ignarro, L.J. (1993). Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 191, 1301-1308
DOI
ScienceOn
|
21 |
Stuehr, D.J. (1997). Structure-function aspects in the nitric oxide synthases, Annu. Rev. Pharmacol. Toxicol. 37, 339-359
DOI
ScienceOn
|